Secondary tumours following etoposide containing therapy for germ cell cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/6/1/35/556465/6-1-35.pdf
Reference33 articles.
1. A model for a curable neoplasm;Einhorn;Cancer Res,1981
2. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vincristine or etoposide;Williams;N Engl J Med,1987
3. Further advances in the management of malignant teratoma of the testis and other sites;Newlands;The Lancet,1983
4. Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours;Pedersen-Bjergaard;Lancet,1991
5. Acute nonlymphocytic leukaemia in germ cell tumour patients treated with etoposide containing chemotherapy;Bajorin;J Natl Cancer Inst,1993
Cited by 98 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy;Frontiers in Oncology;2024-02-02
2. Identification of risk factors and prediction models for secondary malignant neoplasms (SMNs)-free survival and SMNs-specific survival in testicular cancer survivors;World Journal of Urology;2023-08-02
3. In vitro cytotoxic activity, molecular docking study, and chemical composition of Zingiber cassumunar root oil;ScienceAsia;2022
4. Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study;International Journal of Gynecologic Cancer;2021-05-25
5. Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysis;European Journal of Cancer;2020-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3